|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM308612744 |
| 003 |
DE-627 |
| 005 |
20231225132112.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2020 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2020.108413
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1028.xml
|
| 035 |
|
|
|a (DE-627)NLM308612744
|
| 035 |
|
|
|a (NLM)32276139
|
| 035 |
|
|
|a (PII)S1521-6616(20)30205-9
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Han, Yuanyuan
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a COVID-19 in a patient with long-term use of glucocorticoids
|b A study of a familial cluster
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 05.05.2020
|
| 500 |
|
|
|a Date Revised 18.12.2020
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2020 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a Clusters of patients with novel coronavirus disease 2019 (COVID-19) have been successively reported globally. Studies show clear person-to-person transmission. The average incubation period is 2-14 days, and mostly 3-7 days. However, in some patients, this period may be longer. Here, we report a familial cluster of COVID-19 where a 47-year-old woman with long-term use of glucocorticoids did not develop any symptoms within the 14-day quarantine period but was confirmed with COVID-19 by tested positive of antibody on day 40 after she left Wuhan. Almost at the same time, her father and sister were diagnosed with COVID-19. The results suggest that the long-term use of glucocorticoids might cause atypical infections, a long incubation period, and extra transmission of COVID-19
|
| 650 |
|
4 |
|a Case Reports
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a Atypical infection
|
| 650 |
|
4 |
|a COVID-19
|
| 650 |
|
4 |
|a Familial cluster
|
| 650 |
|
4 |
|a Immunocompromised
|
| 650 |
|
4 |
|a Incubation period
|
| 650 |
|
4 |
|a Shedding duration
|
| 650 |
|
7 |
|a Glucocorticoids
|2 NLM
|
| 700 |
1 |
|
|a Jiang, Mao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Xia, Da
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a He, Lichao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lv, Xin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liao, Xiaohua
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Meng, Jie
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 214(2020) vom: 15. Mai, Seite 108413
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:214
|g year:2020
|g day:15
|g month:05
|g pages:108413
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2020.108413
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 214
|j 2020
|b 15
|c 05
|h 108413
|